These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6383598)
1. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. Glauert HP; Reddy JK; Kennan WS; Sattler GL; Rao VS; Pitot HC Cancer Lett; 1984 Sep; 24(2):147-56. PubMed ID: 6383598 [TBL] [Abstract][Full Text] [Related]
2. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Warren JR; Simmon VF; Reddy JK Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917 [No Abstract] [Full Text] [Related]
3. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Lake BG; Evans JG; Cunninghame ME; Price RJ Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414 [TBL] [Abstract][Full Text] [Related]
5. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography. Cattley RC; Richardson KK; Smith-Oliver T; Popp JA; Butterworth BE Cancer Lett; 1986 Dec; 33(3):269-77. PubMed ID: 3802057 [TBL] [Abstract][Full Text] [Related]
6. Induction of unscheduled DNA synthesis in primary rat hepatocytes by benzidine-congener-derived azo dyes in the in vitro and in vivo/in vitro assays. Joachim F; Decad GM Mutat Res; 1984 May; 136(2):147-52. PubMed ID: 6371517 [TBL] [Abstract][Full Text] [Related]
7. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. James NH; Roberts RA Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418 [TBL] [Abstract][Full Text] [Related]
8. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317 [TBL] [Abstract][Full Text] [Related]
9. On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Nilsson R; Beije B; Préat V; Erixon K; Ramel C Chem Biol Interact; 1991; 78(2):235-50. PubMed ID: 2040027 [TBL] [Abstract][Full Text] [Related]
10. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite. Holme JA; Wallin H; Brunborg G; Søderlund EJ; Hongslo JK; Alexander J Carcinogenesis; 1989 Aug; 10(8):1389-96. PubMed ID: 2665964 [TBL] [Abstract][Full Text] [Related]
11. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes. Hong JT; Glauert HP J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Eacho PI; Lanier TL; Brodhecker CA Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515 [TBL] [Abstract][Full Text] [Related]
13. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites. Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285 [TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay). Suter W; Matter-Jaeger I Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280 [TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast. Schiestl RH; Reddy JK Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Parzefall W; Berger W; Kainzbauer E; Teufelhofer O; Schulte-Hermann R; Thurman RG Carcinogenesis; 2001 Mar; 22(3):519-23. PubMed ID: 11238195 [TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats. Miller RT; Shah RS; Cattley RC; Popp JA Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533 [TBL] [Abstract][Full Text] [Related]
18. Lack of release from hepatocytes in vitro or excretion in vivo of mutagenic chrysoidine metabolites. Sandhu P; Chipman JK Toxicol Lett; 1991 Sep; 58(1):43-50. PubMed ID: 1897005 [TBL] [Abstract][Full Text] [Related]
19. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Bieri F; Bentley P; Waechter F; Stäubli W Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407 [TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis. Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]